文献速递运动医学关节外科

血管周干细胞在小型动物模型中减轻巨大肩袖撕裂后的肌肉萎缩

Perivascular Stem Cells Diminish Muscle Atrophy Following Massive Rotator Cuff Tears in a Small Animal Model.
PubMed 文献 · J Bone Joint Surg Am · 2017-01-01

研究在免疫缺陷小鼠巨大肩袖撕裂模型中,比较人脂肪来源血管周干细胞(PSC)经荧光激活细胞分选为周细胞和外膜细胞后注射的效果。结果显示,肌腱切断后注射PSC(预防性或治疗性)及肌腱切断加去神经后治疗性注射PSC,肌肉重量丢失更少、肌纤维横截面积更大(p<0.05)。作者认为PSC可能有助于预防肌肉萎缩而不增加纤维化或脂肪浸润。

要点

  • 肌腱切断后注射PSC(预防性或治疗性)肌肉重量丢失更少、肌纤维横截面积更大(p<0.05)。
  • 肌腱切断加去神经后治疗性注射PSC同样显示肌肉重量丢失更少、肌纤维横截面积更大(p<0.05)。
  • 部分PSC治疗组纤维化和脂肪浸润少于对照,作者认为PSC可能预防肌肉萎缩。

核心结论

  • 与对照相比,PSC治疗组肌肉萎缩显著更少,提示PSC可能在不增加纤维化或脂肪浸润的情况下预防肌肉萎缩。

研究设计与样本

  • 研究使用90只免疫缺陷小鼠,分为15组、每组6只,分别接受假手术、冈上肌腱和冈下肌腱切断术(TT)或TT加肩胛上神经切断去神经(TT+DN)。
  • PSC取自人脂肪抽吸物,经荧光激活细胞分选为周细胞(CD146 CD34 CD45 CD31)和外膜细胞(CD146 CD34 CD45 CD31)。
  • 小鼠接受不注射、注射生理盐水或注射周细胞或外膜细胞,注射时机为索引手术时(预防性)或索引手术后2周(治疗性);索引手术后6周取材分析湿肌肉重量、肌纤维横截面积、纤维化和脂肪浸润。

主要发现

  • TT后PSC治疗(预防性或治疗性注射)及TT+DN后治疗性注射组,肌肉重量丢失少于对照、肌纤维横截面积大于对照(p<0.05)。
  • TT+DN组中,任一时间点注射周细胞或术后2周注射外膜细胞者,纤维化少于TT+DN对照。
  • TT组中,任一时间点注射周细胞或手术时注射外膜细胞者,脂肪浸润少于对照。

临床怎么用

  • 作者认为PSC可能在不增加纤维化或脂肪浸润的情况下预防肌肉萎缩。
  • 作者指出改善肩袖撕裂时的肌肉质量可能提高手术修复成功率并带来更优临床结局。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Rotator cuff tears are a common cause of shoulder pain and often necessitate operative repair. Muscle atrophy, fibrosis, and fatty infiltration can develop after rotator cuff tears, which may compromise surgical outcomes. This study investigated the regenerative potential of 2 human adipose-derived progenitor cell lineages in a murine model of massive rotator cuff tears. METHODS: Ninety immunodeficient mice were used (15 groups of 6 mice). Mice were assigned to 1 of 3 surgical procedures: sham, supraspinatus and infraspinatus tendon transection (TT), or TT and denervation via suprascapular nerve transection (TT + DN). Perivascular stem cells (PSCs) were harvested from human lipoaspirate and sorted using fluorescence-activated cell sorting into pericytes (CD146 CD34 CD45 CD31) and adventitial cells (CD146 CD34 CD45 CD31). Mice received no injection, injection with saline solution, or injection with pericytes or adventitial cells either at the time of the index procedure ("prophylactic") or at 2 weeks following the index surgery ("therapeutic"). Muscles were harvested 6 weeks following the index procedure. Wet muscle weight, muscle fiber cross-sectional area, fibrosis, and fatty infiltration were analyzed. RESULTS: PSC treatment after TT (prophylactic or therapeutic injections) and after TT + DN (therapeutic injections) resulted in less muscle weight loss and greater muscle fiber cross-sectional area than was demonstrated for controls (p < 0.05). The TT + DN groups treated with pericytes at either time point or with adventitial cells at 2 weeks postoperatively had less fibrosis than the TT + DN controls. There was less fatty infiltration in the TT groups treated with pericytes at either time point or with adventitial cells at the time of surgery compared with controls. CONCLUSIONS: Our findings demonstrated significantly less muscle atrophy in the groups treated with PSCs compared with controls. This suggests that the use of PSCs may have a role in the prevention of muscle atrophy without leading to increased fibrosis or fatty infiltration. CLINICAL RELEVANCE: Improved muscle quality in the setting of rotator cuff tears may increase the success rates of surgical repair and lead to superior clinical outcomes.

来源:J Bone Joint Surg Am,查看原文。版权归原作者所有。

引用

  1. Eliasberg CD, Dar A, Jensen AR, et al. Perivascular Stem Cells Diminish Muscle Atrophy Following Massive Rotator Cuff Tears in a Small Animal Model. J Bone Joint Surg Am. 2017. PMID: 28196035. doi:10.2106/JBJS.16.00645

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。